MIRA
INFORM REPORT
|
Report Date : |
01.12.2007 |
IDENTIFICATION
DETAILS
|
Name : |
TEAMNET CORPORATION |
|
|
|
|
Registered Office : |
2-4-8 Iizuka Kawaguchi Saitama-Pref 332-0023 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.05.2007 |
|
|
|
|
Date of Incorporation : |
Jun 2001 |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki Kaisha) |
|
|
|
|
Line of Business : |
Import, export, wholesale of medical
equipment |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Maximum Credit Limit : |
Yen 1 million |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Regular |
name
TEAMNET CORPORATION
REGD NAME
KK Teamnet
MAIN OFFICE
2-4-8 Iizuka Kawaguchi Saitama-Pref 332-0023 JAPAN
Tel : 048-258-8147
Fax : 048-258-8147
URL : http://www.teamnetjp.com
E-mail
: support@teamnetjp.com
ACTIVITIES
Import, export, wholesale of medical equipment
BRANCHES
Nil
OVERSEAS
(Affiliates): Sanrad International, Megachip Instruction Co (--India)
(Distributors): PT Murti Indah Sentosa (Indonesia); Medequips
(Pakistan); CMC Biotech Co (Thailand); Gold Lite Pte Ltd (Singapore), Abex
Medical Systems (Malaysia); GPME Incorporated (Philippines); ViSong Trading
(Shanghai) Development (China)
OFFICERS
MASAFUMI SUZUKI, PRES
Yen Amount: In
million Yen, unless otherwise stated
SUMMARY
FINANCES R/WEAK A/SALES Yen 65 M
PAYMENTS REGULAR CAPITAL Yen 10 M
TREND STEADY WORTH Yen 15 M
STARTED 2001 EMPLOYES 2
COMMENT
IMPORTER AND EXPORTER OF MEDICAL EQUIPMENT. FINANCIAL SITUATION CONSIDERED FAIR AND GOOD
FOR ORDINARY BUSINESS ENGAGEMENTS.
MAX CREDIT LIMIT: YEN 1 MILLION, 30 DAYS NORMAL TERMS.
HIGHLIGHTS
The subject company was established by Masafumi Suzuki in order
to make most of his previous experience with Toshiba Medical Services. This is a one-man operated trading firm
specializing in medical equipment.
About 50% of the exports are into India where the firm has two
affiliates. Also exports to Indonesia,
Pakistan, and Thailand. Imports the
goods from USA.
FINANCIAL INFORMATION
Financials are only partially disclosed.
The sales volume for May/2007 fiscal term amounted to Yen 65 million, a 4% down from Yen 68 million in the previous term. Exports decreased. The net profit was posted at Yen 1 million, unchanged from the previous term.
For the current term ending May 2008 the net profit is
projected at Yen 1 million, on a 5% rise in turnover, to Yen 688 million. Weaker Yen will be following wind to raise
sales in Yen terms.
The financial situation is considered RATHER WEAK but should be
good for MODERATE business engagements.
Max credit limit is estimated at Yen 1 million, on 30 days normal
terms.
REGISTRATION
Date Registered: Jun
2001
Legal Status: Limited
Company (Kabushiki Kaisha)
Authorized: 800
shares
Issued: 200
shares
Sum: Yen
10 million
Major shareholders (%): Masafumi
Suzuki (100)
Nothing detrimental is known as to his commercial morality.
OPERATION
Activities: Exports, imports and wholesales medical instruments
& supplies: imaging system, ICU equipment, others; offering medical English
translation services (--100%).
Clients: [Mfrs, wholesalers] Exports to India (50%), Pakistan (20%), Indonesia (20%), China, other.
No. of accounts: 50
Domestic areas of activities: Centered in greater-Tokyo
Suppliers: [Mfrs, wholesalers] 90% of the goods are supplied
from domestic mfrs; and 10% imported from USA.
Payment record: Regular
Location: Business area in Kawaguchi, Saitama-Pref. Office premises at the caption address are
owned by M Suzuki as his private residence and maintained satisfactorily.
Bank References
Saitama Resona Bank (Kawaguchi)
Relations: Satisfactory
FINANCES
(In Million Yen)
|
Terms Ending: |
|
31/05/2008 |
31/05/2007 |
31/05/2006 |
31/05/2005 |
|
Annual Sales |
|
68 |
65 |
68 |
70 |
|
Recur. Profit |
|
|
|
|
|
|
Net Profit |
|
1 |
1 |
1 |
1 |
|
Total Assets |
|
|
N/A |
N/A |
N/A |
|
Net Worth |
|
|
15 |
14 |
13 |
|
Capital, Paid-Up |
|
|
10 |
10 |
10 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
4.62 |
-4.41 |
-2.86 |
37.25 |
|
|
Current Ratio |
|
|
.. |
.. |
.. |
|
N.Worth Ratio |
|
.. |
.. |
.. |
|
|
N.Profit/Sales |
1.47 |
1.54 |
1.47 |
1.43 |
|
Notes: Financials are only partially disclosed.
Forecast (or estimated) for the 31/05/2008 fiscal term.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)